Drug Channels Archive for August, 2018

Click a link below to view the mailing archive as if it had been sent to you.

2018-08-31 07:12Drug Channels - The State of Specialty Pharmacy 2018: Reflections from #Asembia18 (rerun)
2018-08-30 07:36Drug Channels - EXCLUSIVE: The 340B Program Reached $19.3 Billion in 2017—As Hospitals’ Charity Care Has Dropped (rerun)
2018-08-29 07:41Drug Channels - Who Best Managed the Drug Spending Slowdown in 2017: CVS Health, Express Scripts, MedImpact, or Prime Therapeutics? (rerun)
2018-08-28 07:43Drug Channels - Profits in the 2018 Fortune 500: Manufacturers vs. Wholesalers, PBMs, and Pharmacies (rerun)
2018-08-27 07:34Drug Channels - CBI’s 3rd Edition Drug Pricing Transparency Congress
2018-08-21 07:34Drug Channels - Drug Channels News Roundup, August 2018: PBM Spread Profits, Part D Rebates, 340B Questions, Amazon and Dentists, and PBS on PBMs
2018-08-20 07:45Drug Channels - CBI’s 13th Annual Value-Based Oncology Management Summit
2018-08-16 07:37Drug Channels - 2019 Express Scripts Formulary Exclusions: Hepatitis C Changes Show Why the Drug Channel Must Change, Too
2018-08-14 07:36Drug Channels - New Disclosures Show CVS and Express Scripts Can Survive in a World Without Rebates. Are Plan Sponsors Now the Real Barrier to Disruption?
2018-08-13 07:22Drug Channels - CBI’s Life Sciences Outcomes-Based Contracting Summit
2018-08-10 10:43Drug Channels - Redefining Digital Health: How a Different Approach Can Get Manufacturers Closer to Patients
2018-08-08 07:42Drug Channels - Still Possible: Hospitals Overcharge Health Plans for Specialty Drugs
2018-08-06 07:35Drug Channels - CBI's West Coast Real-Time Benefit Check & ePrior Authorization Summit
2018-08-02 07:36Drug Channels - A System Without Rebates: The Drug Channels Negotiated Discounts Model


<< Archive IndexSubscribe >>